We are live on ! Find out more
MGNX icon

MacroGenics

107 hedge funds and large institutions have $595M invested in MacroGenics in 2014 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 30 increasing their positions, 30 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

256% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 9

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

85% more capital invested

Capital invested by funds: $322M → $595M (+$273M)

26% more funds holding

Funds holding: 85107 (+22)

0% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 30

49% less call options, than puts

Call options by funds: $498K | Put options by funds: $982K

Holders
107
Holders Change
+22
Holders Change %
+25.88%
% of All Funds
2.85%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
32
Increased
30
Reduced
30
Closed
9
Calls
$498K
Puts
$982K
Net Calls
-$484K
Net Calls Change
-$444K

MGNX Hedge Fund Activity: Q4 2014 in Review

107 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q4 2014, worth a combined $595M — up 85% from $322M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new MGNX positions and 9 closed out — a net gain of 23 holders — while 30 added to existing stakes and 30 trimmed.

The largest buyer was Duquesne Family Office, opening a new position worth an estimated $11.8M. The largest seller was TPG Group Holdings (SBS) Advisors, exiting entirely with an estimated $18.4M sold.

  • 107 institutional investors held MacroGenics (MGNX) as of Q4 2014, up from 85 in Q3 2014.
  • Funds reported $595M of MacroGenics stock for Q4 2014, up 85% quarter-over-quarter.
  • 32 funds opened new MacroGenics positions in Q4 2014 and 9 closed out, a net change of +23 holders.
  • The largest MacroGenics buyer in Q4 2014 was Duquesne Family Office, an estimated $11.8M added.
  • The largest MacroGenics seller in Q4 2014 was TPG Group Holdings (SBS) Advisors, an estimated $18.4M sold.

Based on aggregated 13F filings for Q4 2014.